Author

L. Hose

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Assay:imaging· 1

Frequent Co-Authors

A. Lopez-Rodriguez· 2 shared F. Brasch· 2 shared F. Oppel· 2 shared G. Escames· 2 shared H. Pabla· 2 shared H. Sudhoff· 2 shared L. Martinez-Ruiz· 2 shared L. U. Scholtz· 2 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Lopez-Rodriguez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HPV-positive head and neck squamous cell carcinoma cells lose viability during triggered myocyte lineage differentiation

S. Gendreizig, L. Martinez-Ruiz, A. Lopez-Rodriguez, H. Pabla, L. Hose, F. Brasch, T. Busche, G. Escames, H. Sudhoff, L. U. Scholtz, I. Todt, F. Oppel

This study shows HPV+ HNSCC cells lose viability during myocyte-like differentiation in vitro, with upregulated myofibril markers and potential therapeutic implications.

bioRxiv · Mar 28, 2024 · PreprintCancer Biology

Inducible mucosa-like differentiation of head and neck cancer cells drives the epigenetically determined loss of cell malignancy

F. Oppel, S. Gendreizig, L. Martinez-Ruiz, J. Florido, A. Lopez-Rodriguez, H. Pabla, L. Loganathan, L. Hose, P. Kuehnel, P. Schmidt, M. Schuermann, J. M. Neumann, F. Viyof Ful, L. U. Scholtz, D. Ligum, , H. Sudhoff

This study shows that HNSCC cells can differentiate into non-malignant cells, losing their tumor-initiating potential and expressing KRT17, suggesting differentiation as a therapeutic target.

bioRxiv · Jun 30, 2023 · PreprintCancer Biology